Antigua and Barbuda vs Bahamas: Protecting minority investors: Extent of ownership and control index
Antigua and Barbuda
57.14
in 2019
Bahamas
57.14
in 2019
Antigua and Barbuda rank
64th
Bahamas rank
64th
Protecting minority investors: Extent of ownership and control index over time
- Antigua and Barbuda
- Bahamas
How they compare
Antigua and Barbuda currently reports 57.14 against 57.14 in Bahamas, a difference of 0.
The two have swapped places 1 time across 7 shared years of data; in 2013 it was Antigua and Barbuda ahead.
Antigua and Barbuda ranks 64th and Bahamas ranks 64th of 191 countries.
Antigua and Barbuda has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher protecting minority investors: extent of ownership and control index, Antigua and Barbuda or Bahamas?
- Antigua and Barbuda, at 57.14 against 57.14 in Bahamas as of 2019.
- What is the difference in protecting minority investors: extent of ownership and control index between Antigua and Barbuda and Bahamas?
- 0, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Bahamas?
- 7 years are reported by both, from 2013 to 2019.
- How do Antigua and Barbuda and Bahamas rank globally for protecting minority investors: extent of ownership and control index?
- Antigua and Barbuda ranks 64th and Bahamas ranks 64th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Extent of ownership and control index (0-7) (DB15-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for extent of ownership and control index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB15-20 studies.